whole exome sequencing drug

Aliases

WES, whole exome, whole exome sequencing

External links

DrugBank · PubChem

No related entities found.

Mentioned in (37)

Papers in which this entity is mentioned.

• KILDA: identifying KIV-2 repeats from kmers. (2025)
• Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma. (2024)
• Yield of genetic association signals from genomes, exomes and imputation in the UK Biobank. (2024)
• Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
• Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
• Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology. (2021)
• Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
• A practical guide to cancer subclonal reconstruction from DNA sequencing. (2021)
• Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. (2020)
• Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. (2020)
• Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. (2019)
• Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. (2019)
• The mutational constraint spectrum quantified from variation in 141,456 humans (2019)
• Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions. (2019)
• VCF2CNA: A tool for efficiently detecting copy-number alterations in VCF genotype data and tumor purity. (2019)
• Assessment of tumor mutation burden calculation from gene panel sequencing data. (2019)
• Variant calling on the GRCh38 assembly with the data from phase three of the 1000 Genomes Project. (2019)
• Enhanced detection of circulating tumor DNA by fragment size analysis. (2018)
• Tumor fraction in cell-free DNA as a biomarker in prostate cancer. (2018)
• Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. (2018)
• Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. (2017)
• HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. (2017)
• Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. (2017)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. (2017)
• Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience. (2017)
• Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
• A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease. (2016)
• FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. (2016)
• Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
• ENVE: a novel computational framework characterizes copy-number mutational landscapes in colorectal cancers from African American patients. (2015)
• The human gene damage index as a gene-level approach to prioritizing exome variants. (2015)
• Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. (2015)
• Unraveling the clonal hierarchy of somatic genomic aberrations. (2014)
• VariantDB: a flexible annotation and filtering portal for next generation sequencing data. (2014)
• An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. (2014)
• The genomic landscape of hypodiploid acute lymphoblastic leukemia. (2013)

Merged raw entities (3)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.